CrossrefInfokarte
Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
Rheumatology and Therapy · 2025-02 · 12 (1) · 137-155
DOI: 10.1007/s40744-024-00733-7 ↗Abstract
Kein Abstract verfügbar.
EUVIMED